Sophie's research is focused on chemically and physically manipulating biomaterials with the aim of creating technologies that instruct tissue regeneration or overcome clinical challenges. She pursues a multidisciplinary approach to medical device innovation with expertise in chemical synthesis, advanced manufacturing, and formulation engineering. Through working closely with healthcare professionals and industry, Sophie strives to drive our research towards application.
Our translational activities are underpinned by fundamental understanding of disease progression and natural regenerative processes. Employing a multi-modality approach to analyse the physicochemical properties of target tissues enables her team to better recapitulate key performance requirements.
Key current areas of research that Sophie leads, include:
Additive manufacture of customised metallic implants
Modification of medical devices to reduce infection risks
Structuring biomaterials to controllably deliver novel therapeutics
Manufacture, characterisation and use of cell-derived nanoparticles for musculoskeletal regeneration
Multi-modality analysis of the bone – cartilage interface, including dynamic mechanical analysis and micro-computed tomography
In three words or phrases: Student centred; Organised and structured; Inclusive and understanding of the journey .
Provision of Training
Technical training will be offered by members of the group with me taking a lead on supporting you in assessing and developing your professional skills.
Progression Monitoring and Management
I am here to help guide your project with you taking ownership for its progress and decision making on a day-by-day basis. We will be meet formally on a monthly basis and in between there are weekly group meetings / lunches along with opportunity to meet on an ad hoc basis to troubleshoot. I am here to help you make the most of this experience and like to tailor my approach to this so that it works best for you.
The team use Slack (a ‘professional WhatsApp’) to manage daily communications. I value opportunities to meet in person both to discuss technical progress but also to develop our professional relationship. As such our team regularly go for lunch together and organise social occasions. I am very supportive of maintaining a work / life balance that works for you and as such we are supportive of flexible working around laboratory tasks.
PhD Students can expect scheduled meetings with me:
In a group meeting
At least once a week
In year 1 of PhD study
At least once a month
In year 2 of PhD study
At least once a month
In year 3 of PhD study
At least once a fortnight
These meetings will be mainly face to face. I am usually contactable for an instant response on every working day.
The timing of work in my lab is flexible, and other than attending pre-arranged meetings, I expect students to manage their own time.
Notice Period for Feedback
I need at least 1 week's notice to provide feedback on written work of up to 5000 words.
Dr Cox is supervisor on the below project:
Development of a physiologically relevant platform to inform clinical practice and limit antimicrobial resistance in orthopaedic implants
Antibiotics are a cornerstone of modern medicine, and as well as treating infections, are crucial for clinical success in many operations including orthopaedic implants. However, antimicrobial resistance is a growing global health emergency. The World Health Organisation’s “Global Action Plan (GAP) on Antimicrobial Resistance” emphases awareness, education, and prevention, as well as the need for optimisation of current antimicrobial therapies. As such, informing clinical practice of optimal dosing regimes, concentrations and combinations of existing antibiotics as well as novel antimicrobial strategies is a strategic area of focus .
Nonetheless, the available literature has been focused on single molecules or combinations of well-known antibiotics without fully recognising the long-term effect of new bactericidal elements (e.g. silver) in conventional regimes. Novel antimicrobials such as silver or copper are arising across healthcare applications to tackle AMR, however, recent studies have shown that combinations of these elements and current antibiotic practices can result in increased resistance development in vitro . This disregard of novel technologies is further compounded by the limitations inherent to most used methods available to evaluate antimicrobial effectiveness. Only recently has the microbiology community recognised the critical role fluid flow and surface mechanics play in the survival of bacteria in natural environments . Thus, static microtiter assays lack clinical relevance, increasing the potential for antibiotic misappropriation. Considering this, utilising bioreactors has the potential to provide more physiologically relevant and accurate infection models, improving the predictive value of current practices. Consequently, immediate actions against AMR should be focused on optimising antibiotic and antimicrobial treatments through clinically relevant models.
This PhD will develop a physiologically relevant platform to inform orthopaedic clinical practise with the aim of limiting AMR. For this purpose, the experimental plan will be focused in four principal areas:
Ascertain the effectiveness of antibiotic and antimicrobial mixtures, dosing and regimes on the short term and long-term resistance development of an array of clinical and laboratory strains of both Gram positive and negative bacteria typically associated with orthopaedic implant infections.
Unravel the phenotypic and genetic mechanisms behind the observed changes in resistance.
Modification of an existing bioreactor set up to create a physiologically relevant infection model for both planktonic bacteria and orthopaedic device surfaces colonised with early-stage attached bacteria and fully formed biofilms.
Engage with healthcare experts and regulators to optimise current practices.
Hall, T. J. et al. (2020). A call for action to the biomaterial community to tackle antimicrobial resistance. Biomaterials Science, 8(18), 4951-4974.
Villapún, V. M. et al. (2021). Repeated exposure of nosocomial pathogens to silver does not select for silver resistance but does impact ciprofloxacin susceptibility. Acta Biomaterialia, 134, 760-773.
Persat, A. et al. (2015). The mechanical world of bacteria. Cell, 161(5), 988-997.
Previous projects can only be viewed by staff and students. Please make sure you are logged in to see this content.